Wealthcare Advisory Partners LLC Fulgent Genetics, Inc. Transaction History

Wealthcare Advisory Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 15, 2022	BUY	$49.85 - $96.11 $9,970 - $19,222	200 Added 4.11%	5,070 $316,000
Q4 2021 Feb 11, 2022	SELL	$77.3 - $105.0 $4,638 - $6,300	-60 Reduced 1.22%	4,870 $489,000
Q3 2021 Nov 15, 2021	BUY	$74.87 - $110.87 $9,358 - $13,858	125 Added 2.6%	4,930 $443,000
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $143,954 - $216,469	2,155 Added 81.32%	4,805 $443,000
Q1 2021 Apr 30, 2021	BUY	$59.3 - $183.85 $157,145 - $487,202	2,650 New	2,650 $256,000
Q2 2020 Jul 29, 2020	SELL	$8.89 - $18.28 $1,066 - $2,193	-120 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$6.75 - $19.75 $810 - $2,370	120 New	120 $1,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.